-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GHnCd5PA8gRjxGNWlxIjOgkdMXDVxxa7e3ORHi5LCZlNbHTAiODNoh+CVvZt68Vw YztbE3JMFbq15gaBPqwcmg== 0001104659-04-022209.txt : 20040804 0001104659-04-022209.hdr.sgml : 20040804 20040804125955 ACCESSION NUMBER: 0001104659-04-022209 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20040803 ITEM INFORMATION: ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20040804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADAM INC CENTRAL INDEX KEY: 0000863650 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 581878070 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26962 FILM NUMBER: 04950804 BUSINESS ADDRESS: STREET 1: 1600 RIVEREDGE PARKWAY STREET 2: STE 800 CITY: ATLANTA STATE: GA ZIP: 30328 BUSINESS PHONE: 7709800888 MAIL ADDRESS: STREET 1: 1600 RIVEREDGE PKWY STREET 2: STE 800 CITY: ATLANTA STATE: GA ZIP: 30328 FORMER COMPANY: FORMER CONFORMED NAME: A D A M SOFTWARE INC DATE OF NAME CHANGE: 19950919 8-K 1 a04-8756_18k.htm 8-K

 

SECURITIES AND EXCHANGE COMMISSION

Washington D. C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 3, 2004

 

A.D.A.M., INC.

(Exact name of registrant as specified in its charter)

 

Georgia

 

0-26962

 

58-1878070

(State or other jurisdiction
of incorporation)

 

(Commission file number)

 

(I.R.S. Employer
Identification No.)

 

1600 RiverEdge Parkway, Suite 100, Atlanta, Georgia 30328-4696

(Address of Principal Executive Offices)

 

Registrant’s telephone number, including area code: (770) 980-0888

 

 



 

Item 7.                              Financial Statements and Exhibits.

 

The following exhibit is being furnished with this report pursuant to Item 12 of this Form 8-K:

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release of Registrant Regarding Financial Results for the Second Quarter Ended June 30, 2004.

 

 

Item 12.                       Results of Operations and Financial Condition.

 

On August 3, 2004, A.D.A.M., Inc. (the “Company”) issued a press release announcing its financial results for the three and six months ended June 30, 2004. A copy of the press release is furnished herewith as Exhibit 99.1.

 

2



SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

A.D.A.M., Inc.

Date: August 4, 2004

By:

/s/ ROBERT S. CRAMER, JR.

 

 

 

Robert S. Cramer, Jr.

 

 

Chief Executive Officer

 

 

 

 

By:

/s/ KEVIN S. NOLAND

 

 

 

Kevin S. Noland

 

 

President, Chief Operating Officer and Corporate Secretary

 

 

(acting principal financial and accounting officer)

 

3



 

EXHIBIT INDEX

 

Exhibit
Number

 

Exhibit Name

 

 

 

99.1

 

Press Release dated August 3, 2004

 

4


EX-99.1 2 a04-8756_1ex99d1.htm EX-99.1

Exhibit 99.1

 

FOR RELEASE AUGUST 3, 2004 at 7:30am ET

 

A.D.A.M., Inc. Announces Second Quarter Results

 

Company doubles quarterly net income to $0.04 a share, sixth consecutive profitable quarter

 

Atlanta, GA – August 3, 2004 – A.D.A.M., Inc. (Nasdaq: ADAM), a leading developer of interactive health information and decision support tools for the healthcare and education markets, today announced financial results for the second quarter ended June 30, 2004.

 

A.D.A.M, Inc. reported net income for the second quarter of 2004 of $315,000 or $0.04 per fully diluted share as compared to net income of $126,000 or $0.02 per fully diluted share in the year ago quarter.  Revenues for the quarter ended June 30, 2004 were $1,933,000 compared to revenues of $1,934,000 in the year-ago period.

 

A.D.A.M. reported net income for the six-month period ended June 30, 2004 of $540,000 or $0.06 per fully diluted share as compared to net income of $425,000 or $0.05 per fully diluted share for the six months ended June 30, 2003.  Revenues for the six-month period ended June 30, 2004 were $3,684,000 compared to revenues of $4,278,000 during the same period last year. A.D.A.M.’s revenues for the six-month period were lower primarily due to the expiration of a content license agreement the Company had with WebMD Corp. that contributed approximately $600,000 of revenue in the first quarter of 2003. Revenues from the healthcare market increased approximately 17% for the three months ended June 30, 2004 from the year ago quarter. Healthcare revenues for the six-month period ending June 30, 2004 increased approximately 12% compared to the same period last year.

 

As of June 30, 2004, the Company reported cash and investments of $5,195,000 as compared to $4,554,000 as of December 31, 2003.

 

“A.D.A.M. continues to make strong progress across all areas of our business,” said Robert S. Cramer, Jr., Chairman and CEO.  “We are encouraged by our sequential revenue growth of 10% from the March 2004 quarter, and pleased to see improvement in our operating margin as well.  A.D.A.M.’s existing and new products continue to be well received in our various healthcare and education market segments. Looking forward, we intend to focus on growing both our top-line and bottom-line through the remainder of 2004 and into 2005.”

 

Conference Call Information

 

A.D.A.M. will hold its second quarter earnings conference call today, August 3, 2004, at 10:00 A.M. ET. To participate in the call, please dial (877) 829-1372 approximately five minutes prior to the start time.  International callers may dial (706) 679-8134.

 

Forward-Looking Statements

 

Except for historical information, all of the statements, expectations and assumptions contained in this press release are forward-looking statements. These statements, especially revenue, net

 



 

income and cash flow forecasts, involve a number of risks and uncertainties that could cause actual results, performance or developments to differ materially. Factors that could affect the company’s actual results, performance or developments include general economic conditions, development of the Internet as a source of health information, pricing actions taken by competitors, demand for the company’s health information, and changes in laws and regulations that impact how the company conducts its business. A.D.A.M. disclaims any obligation or duty to update any of its forward-looking statements.

 

About A.D.A.M., Inc.

 

Headquartered in Atlanta, A.D.A.M., Inc. (NASDAQ: ADAM) is a leading publisher of interactive, visually engaging health information and decision support tools for healthcare organizations, medical professionals, consumers and students. A.D.A.M. products contain physician-reviewed text, health visuals produced by medically-trained illustrators, and multimedia interactivity to create health information solutions that offer a unique “visual learning” experience in both the healthcare and education markets. Today, A.D.A.M. employs a growing range of media, including Internet, software, CD-ROM, television and print, to deploy its proprietary content assets and products. A.D.A.M. is a founding member of Hi-Ethics, a coalition of the most widely referenced health websites and information providers committed to developing industry standards for the quality of consumer health information. For more information, visit www.adam.com.

 

For further information, contact:

 

Victor Thompson

A.D.A.M., Inc.

(770) 425-7877

 



 

A.D.A.M., Inc.

Condensed Consolidated Statements of Operations
and Summary Balance Sheet Data

 

(In thousands, except per share data)

(Unaudited)

 

 

 

 

Three Months Ended
June 30,
2004

 

Three Months Ended
June 30,
2003

 

Six Months Ended
June 30,
2004

 

Six Months Ended
June 30,
2003

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$

1,933

 

$

1,934

 

$

3,684

 

$

4,278

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Cost of revenues

 

361

 

411

 

729

 

876

 

General and administrative

 

400

 

454

 

747

 

825

 

Product and content development

 

336

 

339

 

600

 

843

 

Sales and marketing

 

385

 

437

 

797

 

960

 

Depreciation and amortization

 

146

 

180

 

297

 

372

 

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

1,628

 

1,821

 

3,170

 

3,876

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

305

 

113

 

514

 

402

 

 

 

 

 

 

 

 

 

 

 

Interest income (expense), net

 

10

 

13

 

26

 

23

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

315

 

126

 

540

 

425

 

 

 

 

 

 

 

 

 

 

 

Basic net income (loss) per common share

 

$

0.04

 

$

0.02

 

$

0.07

 

$

0.06

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average number of common shares outstanding

 

7,923

 

7,129

 

7,874

 

7,050

 

 

 

 

 

 

 

 

 

 

 

Diluted net income (loss) per common share

 

$

0.04

 

$

0.02

 

$

0.06

 

$

0.05

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted average number of common shares outstanding

 

8,702

 

7,943

 

8,639

 

7,785

 

 

 

 

 

Summary Balance Sheet Data

 

 

 

6/30/2004

 

12/31/2003

 

Cash and cash equivalents

 

$

2,568

 

$

4,554

 

Accounts receivable-net

 

2,169

 

1,407

 

Investments, short term

 

1,627

 

 

Total current assets

 

6,899

 

6,355

 

Investments, long term

 

1,000

 

 

Goodwill

 

2,043

 

2,043

 

Total assets

 

11,916

 

10,496

 

Deferred revenue

 

3,109

 

2,295

 

Short term debt

 

11

 

11

 

Total current liabilities

 

3,747

 

2,940

 

Total liabilities

 

3,777

 

2,976

 

Shareholders' equity

 

8,139

 

7,520

 

Working capital

 

3,152

 

3,415

 

 


-----END PRIVACY-ENHANCED MESSAGE-----